338 filings
8-K
PCRX
Pacira BioSciences Inc
13 Jun 24
Departure of Directors or Certain Officers
5:14pm
8-K
PCRX
Pacira BioSciences Inc
14 May 24
Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029
4:00pm
8-K
PCRX
Pacira BioSciences Inc
8 May 24
Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes
4:13pm
10-Q
2024 Q1
PCRX
Pacira BioSciences Inc
Quarterly report
7 May 24
4:02pm
8-K
PCRX
Pacira BioSciences Inc
7 May 24
Pacira BioSciences Reports First Quarter 2024 Financial Results
4:01pm
ARS
uvnv076ao
22 Apr 24
Annual report to shareholders
4:20pm
DEFA14A
prjao9pif
22 Apr 24
Additional proxy soliciting materials
4:17pm
S-8
gvwxruy
29 Feb 24
Registration of securities for employees
5:29pm
8-K
0x1gnh41m 0q7pgj
29 Feb 24
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
8:03am
8-K
nx4tapuj
4 Jan 24
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues
5:02pm
8-K
mmkhzbpggih45rg58cd7
21 Dec 23
Pacira Appoints Frank D. Lee as Chief Executive Officer
7:33am
8-K
yxi9bb8tb btj
2 Nov 23
Pacira BioSciences Reports Third Quarter 2023 Financial Results
8:01am
UPLOAD
kz5v8r
24 Oct 23
Letter from SEC
12:00am
8-K
ux0m1eb8 b7c
10 Oct 23
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
8:02am
CORRESP
4j00z54td 8yl5y
6 Oct 23
Correspondence with SEC
12:00am
8-K
jwir 3gk5ov0s
26 Sep 23
Pacira BioSciences Announces Leadership Succession Plan
4:32pm
UPLOAD
fi41vs3vpylr3hb5
22 Sep 23
Letter from SEC
12:00am